SEGM (@segm_ebm) / X

SEGM

1,288 posts

SEGM

@segm_ebm

Society for Evidence-Based Gender Medicine. Promoting ethical and evidence-informed healthcare for children, adolescents & young adults. (Formerly SEGMtweets)

United States

Joined October 2019

SEGM
@segm_ebm
Mar 10, 2023
The Norwegian Healthcare Investigation Board, (NHIB/UKOM) has deemed puberty blockers, cross-sex-hormones & surgery for children & young people experimental, determining that the current “gender-affirmative” guidelines are not evidence-based and must be revised. /1
1.9M
SEGM
@segm_ebm
Apr 8, 2024
Last week, England shut down the world’s largest pediatric gender clinic at the Tavistock (GIDS). Investigative journalist Hannah Barnes shares 7 lessons for the rest of the world at @segm_ebm NYC conference. Lesson 1: When new evidence emerges, be prepared to change direction.
00:00
387K
SEGM
@segm_ebm
Aug 22, 2022
The President of the American Academy of Pediatrics has announced that gender-affirming hormones & surgery are NOT recommended for the "vast majority" of gender dysphoric youth. This realigns the AAP with Sweden, Finland & the UK's new cautious stance. /1
Opinion | Academy of Pediatrics Responds on Trans Treatment for Kids
From wsj.com
SEGM
@segm_ebm
Mar 31, 2023
The Director of the Belgian Center for Evidence-Based Medicine (CEBAM) Dr. Patrik Vankrunkelsven has joined a growing list of experts who are criticizing the highly medicalized "gender-affirming" treatment approach for minors with gender dysphoria as not evidence-based. /1
VRT NWS
@vrtnws
Mar 29, 2023
Fel debat over puberteitsremmers en mannelijke/vrouwelijke hormonen: "Wat jullie doen, is een experiment op kinderen" vrtnws.be/p.mRVGnWK1E?t=… #vrtnws
770K
SEGM
@segm_ebm
Jan 12, 2023
A new peer-reviewed open-access study exposes deep flaws in the Dutch studies that formed the foundation for youth gender transition. These studies should have never been used to launch the practice into mainstream medicine, conclude the authors./1
segm.org
The Dutch Studies and The Myth of Reliable Research in Pediatric Gender Medicine | SEGM
A new study identifying flaws in gender medicine research demands urgent attention from the medical community
430K
SEGM
@segm_ebm
May 10, 2024
The 128th German Medical Assembly 2024 just passed 2 resolutions: to restrict puberty blockers, cross-sex hormones, and surgeries for gender-dysphoric youth under 18 to controlled clinical trials; and to restrict the self-id laws to those over 18. This is a major development. /1
470K
SEGM
@segm_ebm
May 5, 2021
The Karolinska Hospital in Sweden has issued a policy statement regarding treatment of gender dysphoric minors at its pediatric gender services division. This policy ends the practice of prescribing puberty blockers and cross-sex hormones to minors <16. /1
segm.org
Sweden’s Karolinska Ends All Use of Puberty Blockers and Cross-Sex Hormones for Minors Outside of...
Concerns over medical harm and uncertain benefits result in a major policy shift
SEGM
@segm_ebm
Feb 23, 2022
Yesterday, Sweden released its long-awaited guidelines for the care of gender-dysphoric youth. These guidelines represent a major departure from the WPATH "Standards of Care," and are a vital step towards safeguarding vulnerable youth from medical harm./1
socialstyrelsen.se
Uppdaterade rekommendationer för hormonbehandling vid könsdysfori hos unga
SEGM
@segm_ebm
Apr 11, 2024
We've completed our preliminary analysis of the Cass Report. The "gender-affirming" model of care is over in England, as is the era of the gender-clinic model of care, which exists to deliver youth transitions. This will have world-wide implications./1
segm.org
The Final Cass Review and the NHS England Response | SEGM
Key take-aways from the single most notable event in the history of youth gender medicine of the last decade
184K
SEGM
@segm_ebm
Feb 4, 2025
A new peer-reviewed article examining the criticisms of the Cass Review, just published. The authors found that the primary source of the criticism, a non-peer-reviewed paper published on the Yale Law School website, contains numerous inaccurate and misleading claims. Link👇/1
81K
SEGM
@segm_ebm
Sep 6, 2024
An exceptional summary by Dr. Hilary Cass about the Cass Review, the three key dilemmas it found, and why it is critical to move away from the "gender clinic" model care, which inappropriately treats every gender distressed teen as "transgender."
cambridge.org
Gender identity services for children and young people: navigating uncertainty through communicat...
Gender identity services for children and young people: navigating uncertainty through communication, collaboration and care - Volume 225 Issue 2
205K
SEGM
@segm_ebm
Mar 10, 2023
Replying to @segm_ebm
The UKOM report asserts that future guidelines must rely on a systematic review of evidence rather than cherry-picking studies, and that all hormonal and surgical interventions must be restricted to research settings to ensure clear protocols, safeguarding & adequate follow-up./2
83K
SEGM
@segm_ebm
Mar 15, 2024
The @NHSEngland landmark decision to stop using puberty blockers for gender dysphoric youth raises a key question: what do we know about the effects of puberty blockers on adolescent development? Prof. Sallie Baxendale explored this question at @segm_ebm 2023 conference./1🧵
00:00
206K
SEGM
@segm_ebm
Oct 24, 2022
The NHS has ended "gender-affirming care" in England for <18s, according to the newly-released draft guidance. Psychotherapy will be the first & usually only line of treatment. Puberty blockers will be confined to research settings. SEGM's analysis below:
segm.org
The NHS Ends the "Gender-Affirmative Care Model" for Youth in England | SEGM
The gender-clinic model of care has been replaced with holistic support and appropriate care